Clogrel 75 mg
- Generic
- Clopidogrel Bisulphate
- Manufacturer
- Ad-din Pharmaceuticals Ltd.
- Drug class
- Anti-platelet drugs
Price
৳9 per unit
Packs & prices
- Pack of 45৳405
This is information only. Do not start, stop or switch medicines without a doctor's advice.
Warnings
Contraindications
Precautions
- As it is a prodrug, so metabolism to its active metabolite is impaired by genetic variations in CYP2C19 (poor metabolizer) and by the drugs that inhibit CYP2C19 such as Omeprazole and Esomeprazole. Concomitant use with these drugs and in CYP2C19 poor metaboliser may reduce the antiplatelet activity of Clopidogrel.
- As it inhibits platelet aggregation for the lifetime of the platelet (7-10 days), risk of bleeding may increase. To restore hemostasis, platelet transfusions within 4 hours of the loading dose or 2 hours of the maintenance dose may be less effective.
- Discontinuation of Clopidogrel increases the risk of cardiovascular events. Discontinue 5 days prior to elective surgery that has a major risk of bleeding. Resume Clopidogrel as soon as hemostasis is achieved.
- Thrombotic Thrombocytopenic Purpura (TTP) has been reported that requires urgent treatment including plasmapheresis (plasma exchange).
- Hypersensitivity including rash, angioedema or hematologic reaction has been reported in patients receiving clopidogrel or history of hypersensitivity to other thienopyridines.
Side effects
- Common side effects: Bleeding, Diarrhoea, gastrointestinal discomfort, haemorrhage, Skin reactions.
- Rare side effects: Acquired haemophilia, anaemia, angioedema, arthralgia, arthritis, bone marrow disorders.
Pregnancy & lactation
Drug interactions
- NSAIDs, warfarin, selective serotonin and serotonin norepinephrine reuptake inhibitors (SSRIs, SNRIs): Increases risk of bleeding
- CYP2C19 inhibitors (omeprazole or esomeprazole): Avoid concomitant use of omeprazole or esomeprazole
- Repaglinide (CYP2C8 substrates): Avoid concomitant use of Clopidogrel with Repaglinide as it increases plasma concentrations of Repaglinide
More information
Indications
Recent MI, recent Stroke, or established Peripheral Arterial Disease: In patients with established peripheral arterial disease or with a history of recent myocardial infarction (MI) or recent stroke it is indicated to reduce the rate of MI and stroke.
Dosage
Recent MI, Recent Stroke, or Established Peripheral Arterial Disease: 75 mg once daily orally without a loading dose.
It is given orally with or without food.
Use in children
Overdose
Pharmacology
Therapeutic class
Storage
Source: medex.com.bd · Prescribing information (PDF)
Cheaper alternatives
Same generic, strength and form — sorted by price
Clopigel
Pacific Pharmaceuticals Ltd.
৳9.1
৳0.1 more
Anplat
Jenphar Bangladesh Ltd.
৳10
৳1 more
Carceva
NIPRO JMI Pharma Ltd.
৳10
৳1 more
Clopirel
Novo Healthcare and Pharma Ltd.
৳10
৳1 more
Dogrel
Astra Biopharmaceuticals Ltd.
৳10
৳1 more
Myoclop
Biopharma Laboratories Ltd.
৳10
৳1 more
Silclog
Silco Pharmaceutical Ltd.
৳10
৳1 more
APT
Sharif Pharmaceuticals Ltd.
৳10.03
৳1.03 more
Antiplet
Rangs Pharmaceuticals Ltd.
৳10.03
৳1.03 more
Clopidol
Alco Pharma Ltd.
৳10.03
৳1.03 more
Loplate
Kemiko Pharmaceuticals Ltd.
৳10.03
৳1.03 more
Cardogrel
Pharmasia Limited
৳10.04
৳1.04 more
Lirel
Silva Pharmaceuticals Ltd.
৳10.04
৳1.04 more
Anlet
Globe Pharmaceuticals Ltd.
৳11
৳2 more
Clocard
Aristopharma Ltd.
৳11
৳2 more
39 alternatives in total, showing the 15 cheapest